Zeynep Kacar

Mar 28, 2024 | nature.com | Eric V. Slud |Julián Candia |Xiaolin Wu |Jittiporn Chaisaingmongkol |Mathuros Ruchirawat |Zeynep Kacar | +1 more

AbstractHepatocellular carcinoma (HCC) is a molecularly heterogeneous solid malignancy, and its fitness may be shaped by how its tumor cells evolve. However, ability to monitor tumor cell evolution is hampered by the presence of numerous passenger mutations that do not provide any biological consequences.